How many Reps with Alexion take this go round?

Discussion in 'Lundbeck' started by anonymous, Jan 20, 2018 at 6:21 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I hear Alexion is expanding their Neurology division. Buff up your resume and go to their home page
     

  2. anonymous

    anonymous Guest

    I think you meant WILL take not WITH To answer the question A LOT
     
  3. anonymous

    anonymous Guest

    Most Neuro Account Managers are interviewing everywhere since not much future in Neuro. Lundbeck very cheap with negotiating for new products so deals have failed. Lorena is s puppet for Denmark . Senior leadership scrambling to keep everyone focused . Filling some vacant territories with people desperate for work since managment knows more tenured reps will leave. Its very unfortunate!
     
  4. anonymous

    anonymous Guest

    Do you think upper MGT believes we are so stupid and trust what comes out of their mouths? I would LOVE to be a fly on the wall during an interview. What does the manager say Lundbeck has to offer the interviewee? How does the prospecting employee answer this question with a straight face, why do you want to work for Lundbeck? Will we all be rent a reps soon?
     
  5. anonymous

    anonymous Guest

    I can answer the question "why do you want to work for Lundbeck?" Well that's an easy one! It's because of our superior patient profiles, you silly billy! What other company has patient profiles as wonderful as ours? Nobody that's who! Who needs a pipeline? Who needs a real future? All we need are our patient profiles to get through life.
     
  6. anonymous

    anonymous Guest

    The positions open at Alexion are for Neurology. We don’t have patient profiles in Neurology at Lundbeck. We’re specialty reps with rare disease products.

    Now go take one of the meds you peddle to pcps.
     
  7. anonymous

    anonymous Guest

    Yea, but after this year the only meds left here are the psych ones, so get off your high horse. It is about to kicked out from under you.
     
  8. anonymous

    anonymous Guest

    Did you forget that Northera produces more revenue for Lundbeck than the entire psych portfolio combined and has patent protection to 2021? Probably not since you are clearly stuck in your fantasy land of patient profiles.
     
  9. anonymous

    anonymous Guest

    Onfi's patent loss later this year will not only hurt the neuro sales team, but devastate the company. It's Lundbeck's #1 drug by far. Northera will be hurt by the charitable foundation mess. AM, Trin and Rexulti are going to be in trouble by years end. PIP's are going to popping like popcorn very soon. Only people desperate for work would ever consider Lundbeck. Why would you? You can keep denying what's going on, but sooner or later you will regret at least not testing the water for new opportunities.
     
  10. anonymous

    anonymous Guest

    Why are you here? Are you desperate for work? Life is too short to hate your job.
     
  11. anonymous

    anonymous Guest

    Lundbeck used to be in the orphan drug business. Northera is a drug in search of a real problem- especially at the price it is going for. Oh Well DOJ will take care of that
     
  12. anonymous

    anonymous Guest

     
  13. anonymous

    anonymous Guest

    that story about the starfish shows how naive the people were to buy it. The uniqueness of Lundbeck has been exposed and now the people running this company have no vision or purpose to lead the US based sales force. Where is the inspiration from within? Vegas should be a real interesting meeting.
     
  14. anonymous

    anonymous Guest

    Has anyone heard the chit chat that in Vegas Matt Mays is going to announce we are buying a new drug? I have heard that from more then one person. I do not believe it. The drug would have to be in very late phase 3. There are a few out there. Just wondering.
     
  15. anonymous

    anonymous Guest

    Matt thought we were buying a new drug in the epilepsy market but deal already fell through.
     
  16. anonymous

    anonymous Guest

    We won't be buying any decent drug because we can't out bid the big boys if it's worth a damn. No, we have what we have, and that's it. So what do we do, we waste money on a role play meeting! I mean how stupid can these people be? Just amazing.
     
  17. anonymous

    anonymous Guest

    Weird. I heard they were just going to admit neuro has no future at this company and were just going to terminate all the neuro reps.
     
  18. anonymous

    anonymous Guest

    thats funny, I heard they were going to stop subsidizing psych and let Takeda and otsuka sell the products, no need for the Lundbeck rep.
     
  19. anonymous

    anonymous Guest

    You are both right. Since this company has no pipeline and nothing of value once
    Onfi goes generic and Northera is knee capped by DOJ, they will divest and fire ALL of you.
     
  20. anonymous

    anonymous Guest


    SAD but very true